Fifty years ago, Ashbaugh and colleagues described 12 patients with tachypnea, refractory hypoxemia ... thought to be specific for the respiratory distress syndrome of the newborn.

Their approach employs proprietary algorithms and software ... model-to-support-fibrinolytic-therapy-for-refractory-covid-19-acute-respiratory-distress-syndrome-301055124.html SHARE THIS POST ...

In the sickest cohort of pediatric ARDS patients who become refractory to maximal therapies, some centers have the ability to utilize ECMO as a rescue strategy. Without ECMO, mortality in this ...

We report long-term follow-up of 33 consecutive patients who developed corticosteroid refractory aGVHD in our institution, treated homogeneously according to a unique algorithm combining an ...

For patients with refractory acute respiratory distress syndrome (ARDS) due to COVID-19 infections, extracorporeal membrane oxygenation (ECMO) may be the treatment of last resort. But for reasons ...

Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid-refractory acute graft versus host disease and moderate to severe acute respiratory distress ...

ARDS affectes nearly 10% of patients that arrive to the intensive care unit, and the mortality rate remains stubbornly fixed near 40%. Oxygen microbubbles may provide life-sustaining oxygen during ...

“We are pleased with recent recommendations by FDA’s CBER to meet with the review team and address remaining CMC items for remestemcel-L in the treatment of steroid-refractory acute graft ...

The use of venovenous extracorporeal membrane oxygenation (VV-ECMO) has emerged as a viable treatment option for patients with severe ARDS, Previously considered a rescue therapy for refractory ARDS, ...